Literature DB >> 24901395

Unusual patterns of endometrial carcinoma including MELF and its relation to epithelial mesenchymal transition.

Richard J Zaino1.   

Abstract

Although most of Dr Scully's research addressed diseases of the ovary, about 10% of his published manuscripts focused on endometrial lesions, most often consisting of observations about unusual types or deceptive patterns of endometrial carcinoma that had not previously been described, or lesions for which the behavior had been unknown. He characterized and clarified the entity of clear cell carcinoma of the endometrium, and wrote about endometrial carcinomas with argyrophil, oxyphil, and giant cells, and those simulating microglandular hyperplasia of the cervix, as well as uterine papillary serous, squamous cell, and small cell carcinoma,. He provided a useful classification of precancers of the endometrium and also emphasized the relationship between estrogens and the development of some forms of uterine carcinoma. This article addresses the importance of his careful observations, focusing primarily on the potential relationship of 1 pattern of endometrial carcinoma that he described which has areas of microcystic, elongated, fragmented glands (MELF), frequently accompanied by a fibromyxoid or inflammatory stroma, to the recently described concept of epithelial mesenchymal transition. Endometrioid carcinomas with MELF frequently display a variety of immunohistochemical changes including reduced expression of E-cadherin, B-catenin, estrogen and progesterone receptors, Ki67, and overexpression of fascin, galactin-3, cyclin D1, and p16, as might be expected with epithelial mesenchymal transition. Additional studies will be needed to explain the significance of epithelial mesenchymal transition that occurs in carcinomas with regions of MELF.

Entities:  

Mesh:

Year:  2014        PMID: 24901395     DOI: 10.1097/PGP.0000000000000137

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  7 in total

1.  A fibromyxoid stromal response is associated with an infiltrative tumor morphology, perineural invasion, and lymph node metastasis in squamous cell carcinoma of the vulva.

Authors:  Susanne K Jeffus; Ashita Gehlot; Emily Holthoff; Rebecca Stone; Horace Spencer; Thomas Kelly; Steven R Post; Charles M Quick
Journal:  Am J Surg Pathol       Date:  2015-09       Impact factor: 6.394

2.  Disseminated tumor cells are not associated with established risk factors, L1CAM immunoreactivity and outcome in endometrial carcinoma.

Authors:  Stefan Kommoss; Andreas D Hartkopf; Bernhard Krämer; Anne-Kathrin Bunz; Friederike Grevenkamp; Felix Kommoss; Jana Pasternak; Sabine M Arbabi; Markus Wallwiener; Annette Staebler; Sigurd F Lax; Sara Y Brucker; Florin-Andrei Taran
Journal:  J Cancer Res Clin Oncol       Date:  2017-07-14       Impact factor: 4.553

3.  Prognostic impact of tumor budding in endometrial carcinoma within distinct molecular subgroups.

Authors:  Sara Imboden; Inti Zlobec; Tilman T Rau; Eva Bettschen; Carol Büchi; Lucine Christe; Amanda Rohner; Michael D Müller; Joseph W Carlson
Journal:  Mod Pathol       Date:  2020-07-29       Impact factor: 7.842

4.  Possible Risk Factors of Pulmonary Metastases in Patients With International Federation of Gynecology and Obstetrics Stage I Endometrioid-Type Endometrial Cancer.

Authors:  Wei Jiang; Jun Chen; Xiang Tao; Feifei Huang; Menghan Zhu; Chao Wang; Weiwei Feng
Journal:  Int J Gynecol Cancer       Date:  2017-07       Impact factor: 3.437

5.  The Potential Roles of MELF-Pattern, Microvessel Density, and VEGF Expression in Survival of Patients with Endometrioid Endometrial Carcinoma: A Morphometrical and Immunohistochemical Analysis of 100 Cases.

Authors:  Dmitry Aleksandrovich Zinovkin; Md Zahidul Islam Pranjol; Daniil Rudolfovich Petrenyov; Eldar Arkadievich Nadyrov; Oleg Gennadievich Savchenko
Journal:  J Pathol Transl Med       Date:  2017-09-14

Review 6.  Clinical Use of Progestins and Their Mechanisms of Action: Present and Future (Review).

Authors:  T A Fedotcheva
Journal:  Sovrem Tekhnologii Med       Date:  2021-02-28

7.  L1CAM Expression in Microcystic, Elongated, and Fragmented (MELF) Glands Predicts Lymph Node Involvement in Endometrial Carcinoma.

Authors:  Damiano Arciuolo; Antonio Travaglino; Angela Santoro; Giulia Scaglione; Nicoletta D'Alessandris; Michele Valente; Frediano Inzani; Rossella Accarino; Alessia Piermattei; Roberta Benvenuto; Antonio Raffone; Camilla Nero; Silvia Pelligra; Francesco Fanfani; Massimo Mascolo; Gian Franco Zannoni
Journal:  Cancers (Basel)       Date:  2022-07-26       Impact factor: 6.575

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.